We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+16.75%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$2.45B
AUM Growth
+$190M
Cap. Flow
-$50.3M
Cap. Flow %
-2.05%
Top 10 Hldgs %
18.35%
Holding
310
New
106
Increased
57
Reduced
61
Closed
23

Sector Composition

Rank Sector Weight
1 Healthcare 20.08%
2 Financials 17.24%
3 Consumer Discretionary 15.54%
4 Industrials 14.09%
5 Technology 12.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFST icon
126
Business First Bancshares
BFST
$1.04B
$5.59M 0.23%
224,440
BCML icon
127
BayCom
BCML
$335M
$5.55M 0.23%
244,186
-409
-0.2% -$9.04K
STEL
128
DELISTED
Stellar Bancorp
STEL
$5.45M 0.22%
175,146
CCNE icon
129
CNB Financial Corp
CCNE
$1.05B
$5.45M 0.22%
166,691
-236
-0.1% -$7.38K
PFPT
130
DELISTED
Proofpoint, Inc.
PFPT
$5.35M 0.22%
46,616
-72,923
-61% -$8.69M
KL
131
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$5.33M 0.22%
121,028
-20,362
-14% -$903K
NDLS icon
132
Noodles & Co
NDLS
$108M
$5.22M 0.21%
117,845
MNR
133
DELISTED
Monmouth Real Estate Investment Corp
MNR
$5.07M 0.21%
350,036
-308,666
-47% -$4.56M
EBIX
134
DELISTED
Ebix Inc
EBIX
$4.9M 0.2%
146,565
-195
-0.1% -$7.21K
KNL
135
DELISTED
Knoll, Inc.
KNL
$4.81M 0.2%
190,337
MCS icon
136
Marcus Corp
MCS
$949M
$4.74M 0.19%
149,281
-100,000
-40% -$3.38M
IMDX
137
Insight Molecular Diagnostics
IMDX
$161M
$4.58M 0.19%
101,795
-19,714
-16% -$711K
VCRA
138
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$4.54M 0.19%
218,446
-469,920
-68% -$10.3M
PTLA
139
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$4.5M 0.18%
188,640
-280,344
-60% -$7.73M
SITM icon
140
SiTime
SITM
$16.3B
$4.46M 0.18%
+175,000
New +$3.46M
CSFL
141
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$4.34M 0.18%
173,767
FSBW icon
142
FS Bancorp
FSBW
$323M
$4.24M 0.17%
132,810
OMF icon
143
OneMain Financial
OMF
$7.54B
$4.2M 0.17%
99,650
VNDA icon
144
Vanda Pharmaceuticals
VNDA
$306M
$4.13M 0.17%
+251,730
New +$3.81M
VBTX
145
DELISTED
Veritex Holdings
VBTX
$3.95M 0.16%
135,517
ALTA
146
DELISTED
Altabancorp
ALTA
$3.84M 0.16%
127,472
-1,805
-1% -$52.9K
UNTY icon
147
Unity Bancorp
UNTY
$601M
$3.81M 0.16%
168,750
FMBH icon
148
First Mid Bancshares
FMBH
$1.39B
$3.67M 0.15%
104,051
-30,000
-22% -$1.05M
BOCH
149
DELISTED
Bank of Commerce Holdings (CA)
BOCH
$3.67M 0.15%
316,977
SRCE icon
150
1st Source
SRCE
$2.17B
$3.66M 0.15%
70,605

Similar funds

Emerald Mutual Fund Advisers Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Emerald Mutual Fund Advisers Trust held 310 positions worth $2.45B, up 8.4% from $2.26B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Emerald Mutual Fund Advisers Trust's Q4 2019 filing shows 106 new, 57 increased, 61 reduced and 23 closed positions. Its largest new stake was BellRing Brands: 1,572,144 shares worth $33.5M. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $30.9M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Emerald Mutual Fund Advisers Trust's largest Q4 2019 buy was BellRing Brands: 1,572,144 shares worth $33.5M.
  • Emerald Mutual Fund Advisers Trust added most to Perficient Inc in Q4 2019, an estimated $14.6M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q4 2019 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $30.9M.
  • Emerald Mutual Fund Advisers Trust fully exited Arena Pharmaceuticals Inc in Q4 2019, selling an estimated $12.9M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 18% of its $2.45B portfolio in Q4 2019.
  • Emerald Mutual Fund Advisers Trust opened 106 new positions and closed 23 in Q4 2019.
  • Emerald Mutual Fund Advisers Trust's portfolio value rose 8.4% quarter-over-quarter to $2.45B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2019, filed 29 Jan 2020.